Blue Granite Capital’s Medtronic MDT Stock Holding History

Blue Granite Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,237	Closed	-$563K	–	130
2017 Q3	$563K	Buy	+7,237	New	+$601K	0.39%	74

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Blue Granite Capital's MDT Position: Q4 2017 in Review

Blue Granite Capital sold out of Medtronic (MDT) in Q4 2017, closing a stake of 7,237 shares — an estimated $563K sold.

Blue Granite Capital first reported a position in MDT in Q3 2017 and held it in 1 quarter. The position peaked at $563K in Q3 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

Blue Granite Capital reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
Blue Granite Capital sold 7,237 Medtronic shares in Q4 2017, an estimated $563K.
Blue Granite Capital first reported a position in Medtronic in Q3 2017 and held it in 1 quarter.
Blue Granite Capital's Medtronic position peaked at $563K in Q3 2017.
1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.